日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Novel Interaction Mechanism of a Domain Antibody-based Inhibitor of Human Vascular Endothelial Growth Factor with Greater Potency than Ranibizumab and Bevacizumab and Improved Capacity over Aflibercept

基于域抗体的人类血管内皮生长因子抑制剂的新型相互作用机制,其效力比雷珠单抗和贝伐单抗更强,且比阿柏西普具有更高的容量

Adam Walker, Chun-Wa Chung, Margarete Neu, Manish Burman, Thil Batuwangala, Gavin Jones, Chi-Man Tang, Michael Steward, Michael Mullin, Nadia Tournier, Alan Lewis, Justyna Korczynska, Vicky Chung, Ian Catchpole

Systemic administration of Abeta mAb reduces retinal deposition of Abeta and activated complement C3 in age-related macular degeneration mouse model

全身给药 Abeta mAb 可减少年龄相关性黄斑变性小鼠模型中 Abeta 和活化补体 C3 的视网膜沉积

Ian Catchpole, Volker Germaschewski, Jaimie Hoh Kam, Peter Lundh von Leithner, Susannah Ford, Gerald Gough, Peter Adamson, Philip Overend, Jan Hilpert, Francisco J López, Yin Shan Eric Ng, Pete Coffey, Glen Jeffery

Complement factor h is critical in the maintenance of retinal perfusion

补体因子h对于维持视网膜灌注至关重要

Peter Lundh von Leithner, Jaimie Hoh Kam, James Bainbridge, Ian Catchpole, Gerald Gough, Peter Coffey, Glen Jeffery